UgHerald provides the most timely and comprehensive news coverage of Uganda. It covers a wide range of fields including politics, economy, society, culture, sports, as well as in-depth analysis of international relations and important domestic events. Whether you are concerned about local developments or international influences, this is the best source for the latest information on Uganda. We are committed to helping readers understand the current situation and future of Uganda through accurate, objective and in-depth news reports, while paying attention to the challenges and development opportunities it faces.

About Us

tanzania times : Latest News and In-depth Analysis
Contact Us

Society

HomeSociety

All News

Jan 16, 2025

Baijiayun Made an Appearance at the 2024 Jixin AIGC Summit, Where Vice President Liu Yu Delivered a Wonderful Speech

BEIJING,Jan. 15,2025-- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC),a one-stop AI video solution provider,today announced that it has recently attended the 2024

Jan 16, 2025

AIMA EBIKE Unveils Big Sur Tank at CES 2025: Setting a New Quality Benchmark

LOS ANGELES,Jan. 16,2025--AIMA Ebike unveiled its most anticipated update at CES 2025: the Big Sur Tank,a limited edition model that takes durability,safety,and performance to unprecedented levels. Th

Jan 15, 2025

GenScript upgrades product packaging with a recyclable strategy, reducing waste by 82% and contributing to environmental sustainability

PISCATAWAY,N.J.,Jan. 14,2025-- GenScript Biotech Corporation has unveiled an innovation in shipping packaging,propelling GenScript towards achieving their ambitious sustainability goals. The new packa

Jan 15, 2025

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor,Engineered for Demanding Fleet Applications

Jan 15, 2025

ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL,South Korea,Jan. 14,2025-- ImmunoForge announced that it has received approval for the Phase 2 clinical trial IND for \'Pemziviptadil (development code name PF1804),\' a treatment for DMD (Duch

Jan 15, 2025

2024 China-ASEAN College Students' AI Application Innovation, Recruitment is starting now!

Free registration with generous rewards! High winning rate,and professional project guidance throughout the entire process!

1 ... 89 90 91 92 93 94 95 ... 100